IDWeek 2022
High Rates of PrEP Adherence and Persistence for F/TAF Patients
Patients who are naive to HIV PrEP and prescribed Descovy (Gilead) have a greater number of prescription dispenses, ...
JANUARY 6, 2023
PrEP Awareness High, but Use Low, Among Black and Hispanic Men in U.S.
Awareness of daily oral HIV PrEP is high among Black and Hispanic men in the United States, yet use remains low, ...
DECEMBER 9, 2022
New START Data Reinforces Benefits of Early ART
New START data confirm that starting antiretroviral treatment (ART) early in the course of HIV infection when the ...
DECEMBER 2, 2022
Life Expectancy of Black MSM 6.3 Years Shorter Than White MSM in the U.S.
Early diagnostic testing, improving engagement in care and better adherence to antiretroviral therapy would help ...
NOVEMBER 4, 2022
Load more